CiceroDx, Inc. is the exclusive provider of ReceptivaDx (BCL6) testing for failed IVF, unexplained infertility and recurrent pregnancy loss. Working with over 300 fertility centers in the US and around the world, Our BCL6 marker provides answers for your most challenging cases, even in situations where PGS tested embryos and optimized transfer windows have failed to yield a pregnancy. Stop by to review the latest published clinical data and ongoing research via our NIH commercial grant.